The Week in Review: May 25 – June 1, 2018

Friday, June 1, 2018 News Recap: HCV: Large Study Confirms DAAs Protect Against HCC When Sustained Viral Response Achieved. Patients with hepatitis C virus who are successfully treated with direct-acting antiviral agents experience a dramatic reduction in their risk for liver cancer, new data show. However, the decrease is much lower for those diagnosed with cirrhosis before starting a DAA. HCV Guidance Updated for Screening and Treating Key Popu...

HCV Guidance Updated for Screening and Treating Key Populations

HCVGuidelines.org updated several sections of its website to reflect new hepatitis C virus (HCV) testing and management recommendations for pregnant women, people who inject drugs, men who have sex with men (MSM) and people who are incarcerated. Thanks to direct-acting antivirals, HCV is curable for more than 95% of patients who undergo treatment, according to Marc G. Ghany, MD, MHSc, an HCV Guidance Panel co-chair. “With the success of HCV treatments, th